• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Chiesi Announces Approval of FERRIPROX MR Deferiprone Extended-Release Tablets

    PR NEWSWIRE

    Chiesi Global Rare Diseases Announces Updated U.S. Prescribing FERRIPROX

    PRNEWSWIRE

    Chiesi Global Rare Diseases Announces Approval of FERRIPROX in Brazil for SCD

    PRNEWSWIRE

    Meeting highlights from Committee for Medicinal Products for Human Use (CHMP)

    EMA

    Chiesi Group Receives FDA Approval for Ferriprox® (deferiprone)

    YAHOO

    Chiesi Group Receives FDA Approval for Ferriprox® (deferiprone) twice tablets

    GLOBENEWSWIRE

    Chiesi Group & Apotex Inc. finalize agreement for acquisition of Ferriprox®

    GLOBENEWSWIRE

    Taro Pharm`s Generic Deferiprone Receives Approval in US

    FDA

    Lipomed GmbH`s generic Deferiprone receives approval in Europe

    EMA

    Lipomed GmbH`s Deferiprone Lipomed (deferiprone) Receives Positive CHMP Opinion

    EMA

    Patent Challenges for ApoPharma’s Ferriprox and Akorn’s Zioptan

    TWOFOUR INSIGHT

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.